| Course | IHP 620 Economic Principles of Healthcare |
|---|---|
| Module | Module 9 |
| Paper type | graduate final economic analysis and recommendation |
| Length | About 1,090 words, 6 pages |
| Format | APA 7 student paper |
| School | Southern New Hampshire University |
| Program | MS Healthcare Administration |
| Updated | September 2026 |
Free sample paper for IHP 620 Module 9
Bending the Curve Without Shifting the Burden: Economic Analysis of Granite Peak's Employee Plan
[Student Name]
Southern New Hampshire University
IHP 620: Economic Principles of Healthcare
Module Nine Final Project
[Instructor Name]
[Date]
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Bending the Curve Without Shifting the Burden: Economic Analysis of Granite Peak's Employee Plan
This report advises Granite Peak Health's executive team and benefits committee on how to slow the growth of the employee health plan. It applies economic reasoning and evidence to the plan's cost drivers, compares realistic options and recommends a package that saves money without pushing costs onto the employees least able to bear them.
Executive Summary
Plan costs have risen from $104 million to $142 million in four years and will reach about $193 million in four more if nothing changes. Roughly half of the growth reflects prices charged by outside providers, a quarter specialty drugs, 15% higher use and 10% enrollment. The report recommends against a $2,500 deductible and in favor of a package combining free chronic disease medications, reference pricing for orthopedic surgery and high-cost scans, a bundled orthopedic contract, shared savings with Granite Peak's primary care network and biosimilar adoption, projected to save $12 million to $15 million a year by year three.
The Economics of the Problem
The plan's situation illustrates several economic features of health care. Prices, not quantities, drive most of the growth, reflecting the market power of two outside hospitals. Specialty drug prices are set by manufacturers holding patents. Insurance lowers the price employees see at the point of care, so some use responds to coverage, but that is the smallest driver. And because premium growth is passed on to employees through slower wage growth over time, containing costs is also a way to protect pay.
Why Not a High Deductible
A $2,500 deductible would produce the largest immediate employer savings, about $22.6 million a year. Yet a study by Brot-Goldberg et al. (2017) found that when a large employer made this change, spending fell because employees used fewer services across the board, including potentially valuable care, not because they found cheaper providers. For Granite Peak, a deductible would target the smallest driver of growth, reduce care among employees with chronic conditions and shift costs toward lower-wage staff.
Free Chronic Disease Medications
The package begins by removing copayments for medications that control diabetes, hypertension, high cholesterol, asthma and depression. In a randomized trial, Choudhry et al. (2011) showed that eliminating copayments for key drugs after a heart attack improved adherence and reduced major vascular events or revascularizations, without raising total health spending. At an estimated $2.1 million in yearly drug spending before any savings from fewer complications, the change protects the health of employees most at risk.
Reference Pricing and an Orthopedic Bundle
For hip and knee surgery, back operations and MRI or CT scans, the plan would pay up to a reference price based on Granite Peak's internal costs and the lowest-priced high-quality outside providers. Robinson and Brown (2013) found that when California's public employee program adopted reference pricing for hip and knee replacement, patients shifted to lower-priced hospitals and several high-priced hospitals reduced their prices. A bundled contract with an outside orthopedic center, including a complication warranty, would give employees a no-cost option for surgery Granite Peak does not provide.
Shared Savings With Primary Care
Granite Peak's primary care practices would receive half of any savings below a risk-adjusted spending benchmark for attributed employees, provided quality targets are met. Song et al. (2011) found that in the first year of a commercial global budget contract in Massachusetts, spending growth slowed, largely because participating groups sent scans, lab work and day procedures to cheaper sites, and quality improved. Shared savings give Granite Peak's physicians a reason to do the same.
Specialty Drugs
Through its pharmacy benefit manager, the plan would prefer biosimilars where clinically appropriate and route high-cost drugs through Granite Peak's specialty pharmacy, lowering acquisition costs. This addresses a quarter of growth that benefit design alone cannot reach.
Estimated Effects
The table summarizes projected annual effects by year three. Estimates rest on behavior observed in other settings and are uncertain, so ranges are given.
Table 1. Projected Annual Effects of the Recommended Package by Year Three
| Element | Annual cost | Annual savings | Net effect |
|---|---|---|---|
| Free chronic disease medications | $2.1 million | $1.0-2.0 million | Near neutral |
| Reference pricing and orthopedic bundle | $0.3 million | $6.0-8.0 million | $5.7-7.7 million |
| Shared savings with primary care | $1.5 million (shared) | $3.5-5.5 million | $2.0-4.0 million |
| Biosimilars and specialty pharmacy | $0.2 million | $3.5-4.5 million | $3.3-4.3 million |
| Total | $4.1 million | $14.0-20.0 million | About $12-15 million |
Note. Composite estimates; totals rounded and reflect overlap between elements.
Equity
Unlike a deductible, the package lowers costs for employees with chronic illness, keeps a no-cost surgical option available and does not raise premiums for lower-wage staff. The committee should also consider scaling premium contributions by wage band, since flat contributions take a far larger share of income from a food service worker than from a physician.
Implementation
The package can be introduced over twelve months. In the first quarter, the plan would remove copayments for chronic disease medications and open enrollment in biosimilar programs, changes employees will notice immediately and welcome. In the second quarter, reference pricing and the orthopedic bundle would begin, supported by a price lookup tool, a nurse navigator line and a clear exceptions process. Shared savings with primary care would start at the beginning of the next fiscal year, once attribution rules and the benchmark have been agreed with practice leaders. Communication would rely on managers, benefits fairs and short videos rather than plan documents alone.
Risks
Savings may be smaller than projected if employees do not change providers or if outside hospitals refuse to negotiate. Reference pricing can produce surprise costs if poorly communicated. Shared savings could encourage practices to avoid complex patients without careful risk adjustment. Each risk has a mitigation: clear communication, exceptions processes, risk adjustment and quality gates.
Measures and Review
The committee will track plan cost per member per year, the share of spending at outside facilities, medication adherence for chronic conditions, joint replacement episode costs and complications, biosimilar uptake and employee satisfaction. Results will be reviewed quarterly and the package adjusted after year one.
Recommendation
Granite Peak should adopt the targeted package beginning with the next plan year, phasing in reference pricing and the orthopedic bundle in the first six months and shared savings by the end of year one. The package is projected to cut annual growth roughly in half while improving care for employees with chronic disease and protecting lower-wage staff from new out-of-pocket costs.
Conclusion
Economics explains why Granite Peak's plan costs are rising and why the most obvious response, a higher deductible, would aim at the wrong target. A package focused on prices, drugs and provider incentives addresses the real drivers and fits the system's mission.
References
Brot-Goldberg, Z. C., Chandra, A., Handel, B. R., & Kolstad, J. T. (2017). What does a deductible do? The impact of cost-sharing on health care prices, quantities, and spending dynamics. The Quarterly Journal of Economics, 132(3), 1261-1318. https://doi.org/10.1093/qje/qjx013
Choudhry, N. K., Avorn, J., Glynn, R. J., Antman, E. M., Schneeweiss, S., Toscano, M., Reisman, L., Fernandes, J., Spettell, C., Lee, J. L., Levin, R., Brennan, T., & Shrank, W. H. (2011). Full coverage for preventive medications after myocardial infarction. New England Journal of Medicine, 365(22), 2088-2097. https://doi.org/10.1056/NEJMsa1107913
Robinson, J. C., & Brown, T. T. (2013). Increases in consumer cost sharing redirect patient volumes and reduce hospital prices for orthopedic surgery. Health Affairs, 32(8), 1392-1397. https://doi.org/10.1377/hlthaff.2013.0188
Song, Z., Safran, D. G., Landon, B. E., He, Y., Ellis, R. P., Mechanic, R. E., Day, M. P., & Chernew, M. E. (2011). Health care spending and quality in year 1 of the alternative quality contract. New England Journal of Medicine, 365(10), 909-918. https://doi.org/10.1056/NEJMsa1101416
What the IHP 620 Module 9 instructions ask for
The IHP 620 Final Project generally asks for a complete economic analysis of a decision facing a health care organization: the problem and its drivers, relevant economic concepts, options compared with evidence and estimates, a recommendation, risks and measures. Plan on eight to twelve APA 7 pages. Revise your milestones into one argument for a named decision maker, lead with a summary and show key estimates in tables. Explain why rejected options were rejected, weigh efficiency with equity and phrase the recommendation as something the committee could vote on, with dates attached. IHP 620 graders notice clean headings in IHP 620 papers. IHP 620 names and dates need checking before IHP 620 submission. IHP 620 prompts vary by term, so recheck IHP 620 directions.
How this IHP 620 Module 9 final project example is built
This report advises a composite health system on its $142 million employee plan. An executive summary opens, economic features of the problem follow and a high deductible is rejected using Brot-Goldberg and colleagues. Choudhry and colleagues support free chronic disease drugs, Robinson and Brown support reference pricing and Song and colleagues support shared savings with primary care. A table projects $12 to $15 million in annual net savings, and equity, risks, measures and a phased recommendation close the report. IHP 620 students can reuse this structure for IHP 620 work. IHP 620 claims here trace to cited IHP 620 sources. IHP 620 readers can adapt each section to IHP 620 data.
Where the IHP 620 Module 9 rubric puts the points
Final economic analyses in IHP 620 are usually evaluated on accurate diagnosis of cost drivers, correct use of economic concepts, strong empirical support for each option, clear estimates with ranges, a well-reasoned recommendation, attention to equity and risks, practical measures, evidence that earlier feedback was used, credible sources and APA 7. The best reports explain why the obvious answer is not the best one. Reports lose points when estimates lack ranges, when evidence is thin or when the recommendation ignores who bears the costs. IHP 620 marks favor careful formatting across IHP 620 sections. IHP 620 citations keep every IHP 620 argument credible. IHP 620 instructors weigh evidence heavily in IHP 620 grading.
IHP 620 Module 9 help: the mistakes that cost points
Capstone reports for IHP 620 tend to stumble when the milestones remain visibly separate, presenting savings without ranges or evidence and recommending the option with the largest savings without asking who pays. Another common gap is no timeline or measures. Address one decision-making body, put the answer on page one, tie each element to a cost driver and a study, give estimates with ranges and address equity and risks. Send your three milestones, grader feedback and the IHP 620 rubric so the report builds on your own work. IHP 620 drafts start well from a IHP 620 outline. IHP 620 feedback already received guides IHP 620 revisions. IHP 620 rubrics posted in Brightspace clarify IHP 620 expectations.
Get IHP 620 Module 9 written to your instructions
Hand over the IHP 620 capstone directions, your milestones and your grader's comments. The final analysis will lead with a recommendation, tie each option to evidence and cost drivers, estimate effects with ranges and weigh equity and risk, within 24 to 48 hours, free the first time. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.
More IHP 620 papers and related MS Healthcare Administration samples
- IHP 620 Module 1 Discussion: Why Medical Care Is Not an Ordinary Market
- IHP 620 Module 2 Demand and Cost-Sharing Paper: What Deductibles Do to Spending and to Care
- IHP 620 Module 3 Milestone One: Framing an Employer's Rising Health Plan Costs as an Economic Problem
- IHP 620 Module 4 Market Failure Paper: Adverse Selection, Moral Hazard and a Plan's Choices
- IHP 620 Module 5 Discussion: Why the United States Spends More on Health Care
- IHP 620 Module 6 Milestone Two: Comparing Benefit Designs With Economic Evidence
- IHP 620 Module 7 Cost-Effectiveness Paper: Is a Diabetes Prevention Program Worth Paying For?
- IHP 620 Module 8 Milestone Three: Payment Models That Share Risk With Providers
- IHP 620 Module 10 Journal: Incentives and Fairness in Health Care
- IHP 501 Module 8 Migration and Health Paper: Immigration as a Social Determinant and the Healthy Migrant Paradox
- IHP 610 Module 2 Policy Evidence Paper: What Research Shows About Medicaid Expansion
- IHP 600 Module 10 Journal: Leading People Inside a System
- IHP 604 Module 3 Milestone One: Framing Poor Diabetes Control as a Quality Problem
IHP 620 Module 9 questions, answered
Where can I find a free IHP 620 Module 9 Final Project sample?
IHP 620 Module 9 can be read on this page as a full economic analysis of an employee health plan with options, estimates and a recommendation.
What should the IHP 620 final project include?
The problem and its drivers, economic concepts applied, options compared with evidence and estimates, a recommendation, risks and measures.
Why did the report reject a high deductible?
It targets the smallest cost driver, reduces valuable care and shifts costs to sicker and lower-paid employees.
How should savings estimates be presented?
As ranges based on published evidence, with clear assumptions and a note on overlap between elements.
Should equity be part of an economic analysis?
Yes; who bears costs and benefits matters to decision makers and is usually part of the grading criteria.